Literature DB >> 21138990

mTORC1 signaling: what we still don't know.

Xuemin Wang1, Christopher G Proud.   

Abstract

The mammalian target of rapamycin (mTOR) is a protein kinase that plays key roles in cellular regulation. It forms complexes with additional proteins. The best-understood one is mTOR complex 1 (mTORC1). The regulation and cellular functions of mTORC1 have been the subjects of intense study; despite this, many questions remain to be answered. They include questions about the actual mechanisms by which mTORC1 signaling is stimulated by hormones and growth factors, which involves the small GTPase Rheb, and by amino acids, which involves other GTPase proteins. The control of Rheb and the mechanism by which it activates mTORC1 remain incompletely understood. Although it has been known for many years that rapamycin interferes with some functions of mTORC1, it is not known how it does this, or why only some functions of mTORC1 are affected. mTORC1 regulates diverse cellular functions. Several mTORC1 substrates are now known, although in several cases their physiological roles are poorly or incompletely understood. In the case of several processes, although it is clear that they are regulated by mTORC1, it is not known how mTORC1 does this. Lastly, mTORC1 is implicated in ageing, but again it is unclear what mechanisms account for this. Given the importance of mTORC1 signaling both for cellular functions and in human disease, it is a high priority to gain further insights into the control of mTORC1 signaling and the mechanisms by which it controls cellular functions and animal physiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21138990     DOI: 10.1093/jmcb/mjq038

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  62 in total

1.  Abundance of amino acid transporters involved in mTORC1 activation in skeletal muscle of neonatal pigs is developmentally regulated.

Authors:  Agus Suryawan; Hanh V Nguyen; Rosemarie D Almonaci; Teresa A Davis
Journal:  Amino Acids       Date:  2012-05-30       Impact factor: 3.520

2.  The expanding relevance of nuclear mTOR in carcinogenesis.

Authors:  Jung H Back; Arianna L Kim
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

3.  Status of mTOR activity may phenotypically differentiate senescence and quiescence.

Authors:  Sohee Cho; Eun Seong Hwang
Journal:  Mol Cells       Date:  2012-05-07       Impact factor: 5.034

4.  FKBPs and the Akt/mTOR pathway.

Authors:  Felix Hausch; Christian Kozany; Marily Theodoropoulou; Anne-Katrin Fabian
Journal:  Cell Cycle       Date:  2013-07-01       Impact factor: 4.534

5.  Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma.

Authors:  Heather Francois-Vaughan; Adeola O Adebayo; Kate E Brilliant; Nicola M A Parry; Philip A Gruppuso; Jennifer A Sanders
Journal:  Carcinogenesis       Date:  2016-02-10       Impact factor: 4.944

Review 6.  Aging and cancer: can mTOR inhibitors kill two birds with one drug?

Authors:  Zelton Dave Sharp; Arlan Richardson
Journal:  Target Oncol       Date:  2011-03-11       Impact factor: 4.493

7.  Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo.

Authors:  Jonas Elias Schweig; Hailan Yao; Kyle Coppola; Chao Jin; Fiona Crawford; Michael Mullan; Daniel Paris
Journal:  J Biol Chem       Date:  2019-07-19       Impact factor: 5.157

8.  Tuning cell autophagy by diversifying carbon nanotube surface chemistry.

Authors:  Ling Wu; Yi Zhang; Chengke Zhang; Xuehui Cui; Shumei Zhai; Yin Liu; Changlong Li; Hao Zhu; Guangbo Qu; Guibin Jiang; Bing Yan
Journal:  ACS Nano       Date:  2014-02-25       Impact factor: 15.881

9.  Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy.

Authors:  Zurab Surviladze; Rosa T Sterk; Sergio A DeHaro; Michelle A Ozbun
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  Mechanisms mediating the effects of alcohol and HIV anti-retroviral agents on mTORC1, mTORC2 and protein synthesis in myocytes.

Authors:  Ly Q Hong-Brown; Abid A Kazi; Charles H Lang
Journal:  World J Biol Chem       Date:  2012-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.